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Woellner et al. (2007) evaluated 15
families with autosomal-recessive
hyper IgE syndrome (AR-HIES) and
found that the affected individuals in
five families are homozygous at
marker D19S586 within 1 Mb of the
TYK2 gene, four of the five families
have at least one unaffected child,
and in three of these four, genotype
data are consistent with genetic link-
age to the Tyk2 locus on chromosome
19. The results suggest that homozy-
gous mutation in TYK2 gene is respon-
sible for their AR-HIES. Nevertheless,
the authors performed sequence anal-
ysis on the genomic DNA, but only in
the coding regions of exons and the
adjacent intronic sequences of Tyk2,
and with these data, the authors con-
clude that Tyk2 deficiency is most
likely to not be a common cause of
the AR-HIES.
The sequence analysis of coding
regions of exons and the adjacent in-
tronic sequences of a given gene alone
is not sufficient to identify all of the ex-
isting genetic alterations. Substantial536 Immunity 26, May 2007 ª2007 Elsevpercentage of mutations with large in-
sertions, inversions, and duplications,
as demonstrated in human X-linked
agammaglobulinemia (Rohrer et al.,
1999), could be missed. Therefore, it
may be too early to conclude from their
analysis that Tyk2 deficiency is not
a common cause of the AR-HIES.
More detailed studies on the genomic
structure of the TYK2 gene as well as
the biochemical and functional analy-
ses of Tyk2 protein are needed to
draw the conclusion.
Woellner et al. (2007) also claimed
that humanTyk2deficiency is a distinct
disease entity that is genetically and
clinically different from the patients
with AR-HIES on the basis of their
experimental data. However, as de-
scribed in our previous report (Mine-
gishi et al., 2006), the patient with
Tyk2 deficiency displayed clinical fea-
tures characteristic of AR-HIES, with
clinical and laboratory scores high
enough to diagnose as HIES accord-
ing to the National Institutes of Health
scoring system that was developed
for HIES diagnosis (Grimbacher et al.,
1999). In addition, the patient showed
clinical features of Mendelian sus-
ceptibility to mycobacterial diseaseier Inc.(MSMD) (Casanova and Abel, 2004).
Therefore, we think that Tyk2 defi-
ciency should be categorized as a
disease entity having characteristic
features of both AR-HIES and MSMD.
Further genetic analyses of HIES pa-
tients including autosomal-dominant
and sporadic forms should clarify this
issue.
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